NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone

Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors (e.g., FK866) target the most active pathway of NAD(+) synthesis in tumor cells, but lack tumor-selectivity for use as a single agent. Reducing NAD(+) pools by inhibiting NAMPT primed pancreatic ductal adenocarcinoma (PDA) cells for poly(ADP...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Z, Chakrabarti, G, Luo, X, Ali, A, Hu, Z, Fattah, F J, Vemireddy, R, DeBerardinis, R J, Brekken, R A, Boothman, D A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669762/
https://www.ncbi.nlm.nih.gov/pubmed/25590809
http://dx.doi.org/10.1038/cddis.2014.564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669762/
https://www.ncbi.nlm.nih.gov/pubmed/25590809
http://dx.doi.org/10.1038/cddis.2014.564

Ejemplares similares